Patency of Perforating Arteries after Stent Placement? A Study Using an In Vivo Experimental Atherosclerosis-Induced Model

References

1. ↵
   WASID Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis: the warfarin-aspirin symptomatic intracranial disease (WASID) study group. Stroke 1998;29:1389–1392

   Abstract/FREE Full Text
2. Chimowitz MI, Kokkinos J, Strong J, et al. The warfarin-aspirin symptomatic intracranial disease study. Neurology 1995;45:1488–1493

   Abstract/FREE Full Text
3. ↵
   Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490–497

   Abstract/FREE Full Text
4. ↵
   The EC/IC Bypass Study Group. Failure of extra-cranial/intracranial arterial bypass to reduce the risk of ischemic stroke: result of an international randomized trial. N Engl J Med 1985;313:1191–1200

   PubMedWeb of Science
5. ↵
   Lanzino G, Fessler RD, Miletich RS, Guterman LR, Hopkins LN. Angioplasty and stenting of basilar artery stenosis: technical case report. Neurosurgery 1999;45:404–408

   PubMedWeb of Science
6. Horowitz MB, Pride GL, Graybeal DF, Purdy PD. Percutaneous transluminal angioplasty and stenting of midbasilar stenoses: three technical case reports and literature review. Neurosurgery 1999;45:925–931

   PubMedWeb of Science
7. Mori T, Kazita K, Mori K. Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol 1999;20:787–789

   Abstract/FREE Full Text
8. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95–99

   Abstract/FREE Full Text
9. Gomez CR, Misra VK, Cambell MS, Soto RD. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 2000;21:971–973

   Abstract/FREE Full Text
10. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia. Neurosurgery 2001;48:1215–1223

    CrossRefPubMedWeb of Science
11. Uchiyama N, Kida S, Watanabe T, Yamashita J, Matsui O. Improved cerebral perfusion and metabolism after stenting for basilar artery stenosis: technical case report. Neurosurgery 2001;48:1386–1392

    PubMed
12. Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C. Endovascular reconstruction of intracranial arteries by stent placement and combined techniques. J Neurosurg 2002;97:1306–1313

    PubMedWeb of Science
13. Levy EI, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar stenosis. J Neurosurg 2002;97:1294–1301

    PubMedWeb of Science
14. ↵
    Shin YS, Kim SY, Bang OY, et al. Early experiences of elective stenting for symptomatic stenosis of the M1 segment of the middle cerebral artery: reports of three cases and review of the literature. J Clin Neurosci 2003;10:53–59

    CrossRefPubMed
15. ↵
    Masuo O, Terada T, Walker G, et al. Study of the patency of small arterial branches after stent placement with an experimental in vivo model. AJNR Am J Neuroradiol 2002;23:706–710

    Abstract/FREE Full Text
16. ↵
    Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis: a nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol 1996;16:34–43

    Abstract/FREE Full Text
17. ↵
    Carter AJ, Farb A, Gould KE, Taylor AJ, Virmani R. The degree of neointimal formation after stent placement in atherosclerotic rabbit iliac arteries is dependent on the underlying plaque. Cardiovasc Pathol 1999;8:73–80

    CrossRefPubMedWeb of Science
18. Tominaga R, Harasaki H, Sutton C, Emoto H, Kambic H, Hollman J. Effects of stent design and serum cholesterol level on the restenosis rate in atherosclerotic rabbits. Am Heart J 1993;126:1049–1058

    CrossRefPubMedWeb of Science
19. ↵
    Welt FG, Woods TC, Edelman ER. Oral heparin prevents neointimal hyperplasia after arterial injury. Circulation 2001;104:3121–3124

    Abstract/FREE Full Text
20. ↵
    Poerner TC, Kralev S, Voelker W, et al. Natural history of small and medium-sized side branches after coronary stent implantation. Am Heart J 2002;143:627–635

    CrossRefPubMedWeb of Science
21. ↵
    Levy EI, Boulos AS, Hanel RA, et al. In vivo model of intracranial stent implantation: a pilot study to examine the histological response of cerebral vessels after randomized implantation of heparin-coated and uncoated endoluminal stents in a blinded fashion. J Neurosurg 2003;98:544–553

    PubMed
22. ↵
    Lopes DK, Ringer AJ, Boulos AS, et al. Fate of branch arteries after intracranial stenting. Neurosurgery 2003;52:1275–1279

    PubMedWeb of Science
23. ↵
    Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107:381–383

    Abstract/FREE Full Text
24. Park SJ, Shim WH, Ho DS, et al. A parlitaxel-eluting stent for prevention of coronary restenosis. N Engl J Med 2003;348:1537–1545

    CrossRefPubMedWeb of Science
25. ↵
    Schofer J, Schluter M, Gershlick AH, et al, E-SIRIUS Investivators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind randomized controlled trial (E-SIRIUS). Lancet 2003;362:1093–1099

    CrossRefPubMedWeb of Science
26. ↵
    Tanabe K, Serruys PW, Degertekin M, et al. Fate of side branches after coronary arterial sirolimus-eluting stent implantation. Am J Cardiol 2002;90:937–941

    CrossRefPubMedWeb of Science